The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
about
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraAcquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from JapanSplenectomy for the treatment of thrombotic thrombocytopenic purpura.Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.National survey of hemapheresis practice in Hungary 2001-2004.Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy.Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasmaSerial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Rituximab therapy in pemphigus and other autoantibody-mediated diseases.
P2860
Q24651320-B30731EF-B1F2-4FAB-9FF3-38E1A50B857CQ28731380-3522B0E2-9E78-4259-90EC-32ECACE3EE1AQ33368032-2D9608C3-C525-46EF-88C7-15DB79FD41BCQ33369692-121C784B-908A-456C-9A24-E87868B6C28DQ33371103-27C78900-A7E7-4D70-A582-03B8A0C80B74Q33374294-13412AD8-674E-41F4-B8FC-03395A7A312BQ33374298-F0396F22-9CAF-4E33-86AC-372461018844Q33375632-6B9EDAF8-3FB6-4F02-92C3-27C38BA37E2BQ33375739-CC92C07F-6F81-4690-8303-1C381266097AQ33380771-7DEDFC79-E2E1-42B2-95D9-49CBEF78DAD0Q33394765-BC685FBD-3013-41F3-94D4-D1289839CD64Q33400631-54F1C7E2-EB42-4EC2-83F7-C0AB6E5A9709Q33401403-8416166F-92D7-40DB-98F3-3AF7F03E4139Q33402749-117162C7-A945-45C3-9C6B-B91189DEFDD0Q33416047-62B6F7CD-E9AC-43A7-AD57-92D1F0710B30Q33416588-605B3880-AB53-4A88-81D2-566F7AA55E44Q33418539-C8101E44-A67C-4F07-AB5C-7C99D50040DCQ33423510-0A5C3F9B-6A1C-4E5F-B75C-97DD8CD63C50Q33425441-CA84935C-942D-4622-9A3D-14646CFFCD13Q33425489-0F90A9CD-3A3D-48C0-A6D6-4036A393D63DQ33431806-64C5CA9E-1609-4E2E-AB35-F8116DEB6BE0Q37620483-D2A2F7F5-0340-4EFD-8AF2-6EF29F32D9F0
P2860
The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@ast
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@en
type
label
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@ast
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@en
prefLabel
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@ast
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@en
P2093
P2860
P1476
The course of ADAMTS-13 activi ...... asma exchange and vincristine.
@en
P2093
Charis von Auer
Christoph Betz
Helmut Geiger
Inge Scharrer
Manuela Krause
Martina Böhm
Wolfgang Miesbach
P2860
P304
P356
10.1111/J.1365-2141.2005.05512.X
P407
P577
2005-06-01T00:00:00Z